Both in Diagnostics
Intellia Therapeutics vs Neogen
Over the past year NTLA returned −5.0% and NEOG returned +100.5%; their daily moves had a correlation of 0.14.
NTLA −5.0% NEOG +100.5%Growth of $1, one year, split-adjusted
| Metric | NTLA | NEOG |
|---|---|---|
| Price | $12.42 | $12.61 |
| Market cap | $1.74B | $2.75B |
| Today | +4.68% | +4.21% |
| 1 month | +0.4% | +5.4% |
| 6 months | −10.4% | +37.4% |
| Year to date | +38.1% | +80.4% |
| 1 year | −5.0% | +100.5% |
| Revenue growth (YoY) | −46.2% | +6.5% |
| Gross margin | 100.0% | 47.4% |
| Net margin | −1392.3% | −5.3% |
| P/E (TTM) | — | — |
| Price / sales | 29.2× | 3.1× |
| Net cash | $437.8M | -$605.6M |
| Dividend yield | — | — |
| Volatility (60d) | 63.3% | 42.6% |
| Short % of float | 38.6% | 5.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).